| |
| |
|
| Insider
Information: |
Yancopoulos George |
| Relationship: |
Bd. Co-Chair, Presiden... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
786,383 |
|
|
Indirect Shares
|
362,461 |
|
|
| Direct
Value |
$788,702,830 |
|
|
|
Indirect Value
|
$363,530,260 |
|
|
| Total
Shares |
1,148,844 |
|
|
| Total
Value |
$1,152,233,090 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
Bd. Co-Chair, Presiden... |
2024-05-16 |
786,383 |
2024-05-16 |
362,461 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
145 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2003-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,277 |
64,817 |
|
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO President Regeneron Re |
• • – |
2006-05-19 |
4 |
GD |
$0.00 |
$0 |
D/D |
670 |
62,424 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP, CSO, & Pres Regn Res Labs |
• • – |
2007-12-17 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
563,094 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO & Pres Regn Res Labs |
• • – |
2010-12-14 |
4/A |
A |
$0.00 |
$0 |
D/D |
250,000 |
870,375 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP CSO Pres REGN Res Lab |
• • – |
2012-06-27 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
1,333,041 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
568,343 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-02-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
568,343 |
568,343 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-08-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
294 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-08-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
294 |
568,637 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-11-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,313 |
566,324 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
3,264 |
569,588 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2014-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,264 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2015-11-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
43,348 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2015-11-02 |
4 |
GA |
$0.00 |
$0 |
I/I |
43,348 |
612,936 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2015-11-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,612 |
567,976 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2015-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,921 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2015-12-17 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,921 |
569,897 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-07-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
500,000 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President Regeneron Laboratori |
• • – |
2016-07-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
500,000 |
67,976 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2016-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
89,427 |
500,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2016-12-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
89,427 |
159,324 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President & CSO |
• • – |
2016-12-20 |
5 |
GD |
$0.00 |
$0 |
I/I |
3,918 |
64,058 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-07-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
176,223 |
331,629 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-07-21 |
4 |
GD |
$0.00 |
$0 |
I/I |
176,223 |
323,777 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
President and CSO |
• • – |
2017-08-03 |
4 |
GA |
$0.00 |
$0 |
I/I |
176,223 |
176,223 |
0 |
- |
|
145 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
